- In April 2024, Thermo Fisher Scientific launched its ENERGY STAR Certified TSX Universal Series ULT Freezers, designed to enhance temperature control and improve recovery times. These advanced freezers provide more precise temperature stability, allowing for better preservation of sensitive biological samples. The ENERGY STAR certification ensures superior energy efficiency, contributing to cost savings and sustainability in research labs
- In April 2024, Sartorius partnered with TheWell Bioscience to enhance drug discovery forecasting. By leveraging advanced technologies, they aim to improve accuracy in predicting drug responses and outcomes. This collaboration focuses on integrating high-quality data to optimize the drug development process, enabling pharmaceutical companies to accelerate innovations and achieve better results in the development of therapeutic treatments
- In January 2024, Merck’s Life Science division signed a Memorandum of Understanding with Mycenax Biotech to explore innovative bioprocessing solutions. This collaboration aims to bring cutting-edge biomanufacturing capabilities to Taiwan and other global markets. The partnership is focused on advancing production technologies that will enhance the efficiency and scalability of bioprocesses for the pharmaceutical and biotechnology sectors
- In June 2022, Thermo Fisher Scientific introduced the Thermo Scientific PAC Neo HPLC Column, designed to simplify complex bottom-up proteomics analyses. Offered exclusively with the Thermo Scientific Vanquish Neo UHPLC System and Orbitrap Mass Spectrometers, this integrated solution provides researchers with a comprehensive LC-MS workflow. This combination ensures optimal performance, reducing setup time and enhancing experimental reliability
- In May 2022, Tosoh Bioscience LLC released the TSKgel UP-SW30000-LS size exclusion chromatography (SEC) columns for biomolecule separation. These columns, part of the TSKgel UP-SW series, are now available for purchase in the Americas. With their innovative design, they provide researchers with improved separation efficiency for large biomolecules, enabling more accurate analysis in life sciences and biotechnology applications
- In February 2022, Merck announced organizational changes and a new operating model to support the long-term growth of its Life Science business sector. The company aims to meet evolving global market demands by optimizing its structure and strategies. These changes are designed to strengthen Merck’s leadership in science and technology, positioning it to address the future needs of its international clients
- In November 2021, Thermo Fisher Scientific acquired PharmaFluidics, a Belgian company known for its micro-chip-based chromatography columns. PharmaFluidics’ PAC series columns are revolutionizing chromatography by offering high-resolution separation in analytical applications. This acquisition strengthens Thermo Fisher’s portfolio of scientific tools, enabling them to provide advanced solutions for customers in the life sciences and analytical chemistry sectors
